MIR3199-1

Across TCGA pan-cancer cohorts, MIR3199-1 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MIR3199-1 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher MIR3199-1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR3199-1 expression acts as an unfavorable survival marker, although some lineages such as CESC and BRCA show a favorable association.

CESC, BRCA, and UVM are the cancer types where MIR3199-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	II,III,IV	1.000	0.504	.035	54	view →
BRCA	DFS	Tertile	IV	0.705	0.195	.003	36	view →
UVM	OS	Tertile	All	0.266	0.792	<.001	27	view →
ACC	DFS	Tertile	All	0.377	0.691	.016	21	view →
THCA	OS	Tertile	IV	0.626	1.000	.002	18	view →
MESO	DFS	Tertile	II,III,IV	0.225	0.425	.028	18	view →
LUSC	DFS	Tertile	All	0.889	0.656	.014	12	view →
PRAD	DFS	Tertile	All	1.000	0.876	.026	12	view →
GBM	DFS	Tertile	All	0.084	0.291	.016	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
CHOL	DFS	Median	II,III,IV	0.708	0.220	.049	3	view →
PCPG	DFS	Tertile	All	0.728	0.940	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MIR3199-1–CESC (OS)

Open the CESC breakdown →